Health Catalyst CEO Albert Benjamin forfeited 321 shares at $1.70 per share, reducing his holding through the transaction. For investors, the disclosed post-transaction ownership is 1,423,650 shares, while the transaction was dated Sept. 1, 2026 and carried transaction code F.
Key Highlights
- Albert Benjamin held 1,423,650 Health Catalyst shares after the transaction.
- The transaction carried code F.
- Health Catalyst CEO Albert Benjamin forfeited 321 shares in the reported transaction.
Health Catalyst, Inc. (NASDAQ: HCAT) recorded the forfeiture of 321 shares at $1.70 per share by CEO Albert Benjamin. After the transaction, he owned 1,423,650 shares.
Albert Benjamin’s Health Catalyst Ownership After Transaction
The transaction was dated Sept. 1, 2026. Benjamin serves as Health Catalyst’s chief executive officer and was the executive involved in the share forfeiture. The transaction carried code F. The disclosed per-share value was $1.70, and the number of shares forfeited was 321. That post-transaction balance is the stated holding associated with the event.
FAQs
Q: How many Health Catalyst shares did Albert Benjamin forfeit?
A: Health Catalyst CEO Albert Benjamin forfeited 321 shares in the reported transaction. The shares were valued at $1.70 per share, and the transaction was dated Sept. 1, 2026.
Q: How many Health Catalyst shares does Albert Benjamin own after the transaction?
A: Albert Benjamin’s reported Health Catalyst ownership following the transaction was 1,423,650 shares. This is the disclosed balance associated with the transaction dated Sept. 1, 2026.
Q: What was the price of Albert Benjamin’s Health Catalyst share transaction?
A: The reported Health Catalyst share transaction was valued at $1.70 per share. It involved 321 shares forfeited by Albert Benjamin and carried SEC transaction code F.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.